Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Invested Capital (2018 - 2025)

Dna X's Return on Invested Capital history spans 8 years, with the latest figure at 1.8% for Q3 2025.

  • Quarterly results put Return on Invested Capital at 1.8% for Q3 2025, up 260.0% from a year ago — trailing twelve months through Sep 2025 was 1.8% (up 260.0% YoY), and the annual figure for FY2024 was 0.4%, down 42.0%.
  • Return on Invested Capital for Q3 2025 was 1.8% at Dna X, up from 0.05% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 1.8% in Q3 2025 to a low of 3.7% in Q2 2022.
  • The 5-year median for Return on Invested Capital is 0.7% (2024), against an average of 0.91%.
  • The sharpest move saw Return on Invested Capital tumbled -197bps in 2022, then soared 360bps in 2023.
  • Year by year, Return on Invested Capital stood at 2.42% in 2021, then soared by 71bps to 0.71% in 2022, then soared by 102bps to 0.01% in 2023, then plummeted by -5552bps to 0.7% in 2024, then soared by 360bps to 1.8% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 1.8%, 0.05%, and 0.03% for Q3 2025, Q2 2025, and Q1 2025 respectively.